The U.S. Food and Drug Administration has approved Vizz 1.44% (aceclidine ophthalmic solution) for the treatment of presbyopia in adults. Vizz is the first and only aceclidine-based eye drop to ...

A new eye drop, Vizz, was recently FDA approved and is helping people regain near vision without glasses. Originally used for glaucoma, the drops are now repurposed for presbyopia (age-related ...

CORONA, CA, UNITED STATES, March 5, 2026 /EINPresswire.com/ — B&B Optometry, under the clinical leadership of Dr. Seth Bernstein, is now offering Vizz prescription ...

A new once-a-day eye drop designed to improve blurry vision in adults is now commercially available in the United States. The product, known as VIZZ 1.44%, offers a nonsurgical option for people ...

Presbyopia is defined as age-related loss of near vision that affects nearly everyone over age 45. The FDA has approved Vizz, an aceclidine ophthalmic solution 1.44%, making it the first and only ...

Credit: Lenz Therapeutics. Aceclidine is a cholinergic muscarinic agonist that causes contraction of the iris sphincter muscle, thereby creating a pinhole effect that extends focus depth to improve ...